Mercator Medical Sa · GPW:MRC

Mercator Medical Sa — Investor Presentation (2021)

42 slides from Mercator Medical Sa's investor presentation, 2021

  1. Slide 1: Mercator

    MERCATOR

  2. Slide 2: Agenda

    AGENDA COMPANY OVERVIEW OUR PRODUCTS FINANCIAL AND OPERATING RESULTS SUMMARY

  3. Slide 3: Company Overview

    SSS... MERCATOR COMPANY OVERVIEW

  4. Slide 4: Mercator Group

    MERCATOR GROUP We sell our products in over 70 countries with a 2% share companies in the global market succeeds on the global medical glove market dominated by Asian companies and one of several conglomerates in the world that manufacture medical gloves in Asia and distribute them globally 6,2 k gl

  5. Slide 5: Our History

    OUR HISTORY ▪ entering the sector of public ▪ setting up a branch in Hungary; ▪ adding surgical drapes tenders; ▪ establishing a subsidiary Mer- and drape sets to offer; ▪ opening a central warehouse kator Medikal TOB in Ukraine, ▪ setting up a distribution and a Sales Office in Stary cooperation wi

  6. Slide 6: Our History

    OUR HISTORY ▪ signing a set of long-term and short-term loan agreements with CIMB Thai Bank based in Thailand (total value: over PLN 86 million); ▪ rebranding of household and protective gloves; new development ▪ establishing a subsidiary Mercator Medical strategy for the years 2016-2018; opening a

  7. Slide 7: Mercator Medical Group

    MERCATOR MEDICAL GROUP Mercator Medical s.r.o. (Czech Republic) Mercator Mercator Medical s.r.l. Medical KFT. (Romania) (Hungary) Merctor Mercator Medical TOB Medical OOO (Ukraine) (Russia) Mercator Mercator Medical Medical (Thailand) Ltd. Italia s.r.l. (Thailand) (Italy) Mercator Medical GmbH (Germ

  8. Slide 8: The Management Board

    THE MANAGEMENT BOARD Wiesław Żyznowski, PhD Monika Żyznowska Michał Romański Dariusz Krezymon Chief Financial Officer CEO of Mercator Medical President of the Board, Member of the Board since 2021. (Thailand) and Member of the major shareholder, since 2017 Member of the Board Board of Mercator Medic

  9. Slide 9: Field of Activity

    FIELD OF ACTIVITY Poland Thailand The companies of Mercator Medical Group Sales: are present in the following countries covered by the distribution Poland Thailand Hungary of the Group branches Czech Romania Italy covered by the factory in Thailand Russia Ukraine Germany

  10. Slide 10: Mercator Thailand

    MERCATOR THAILAND 3 annual production bln capacity 1063 today’s number of employees 2006 established year main product examination and industrial nitrile gloves located in the prime rubber production area of the Ratthapum district, Songkhla province in southern Thailand

  11. Slide 11: Medical Gloves Producer

    MEDICAL GLOVES PRODUCER CONVENIENT LOCATION OF THE FACTORY NEAR 2 PORTS: 95% OF PRODUCTION CAPACITY IS SOLD UNDER OEM SONGKHLA THAILAND, PENANG MALAYSIA CUSTOMISATION OF CONTAINER FREIGHT SUPPLIES in the scope of the mix of products, appearance, packaging size and quality and the manner of container

  12. Slide 12: The Company Is SA 8000 Certified

    MEDICAL GLOVES PRODUCER THE COMPANY IS SA 8000 CERTIFIED SA 8000 – SOCIAL ACCOUNTABILITY CERTIFICATION SA 8000 is an international certification standard that encourages organizations to develop, maintain and apply socially acceptable practices in the workplace. SA 8000 certification addresses issue

  13. Slide 13: Nitrile Glove Factory in Thailand: Ecology

    NITRILE GLOVE FACTORY IN THAILAND: ECOLOGY SOLAR PANELS 7000 m2 of surface area -25% of energy costs dedicated computer software managing energy at the establishment WASTE WATER TREATMENT PLANT 2000 m3 of water suitable for the production process a day -74% of water costs

  14. Slide 14: Agenda

    AGENDA COMPANY OVERVIEW OUR PRODUCTS FINANCIAL AND OPERATING RESULTS SUMMARY

  15. Slide 15: Our Products

    SSS... MERCATOR OUR PRODUCTS

  16. Slide 16: Examination Gloves

    EXAMINATION GLOVES Diagnostic gloves are the most important factor in the process of preventing infections. They provide the best protective barrier against microorganisms. The gloves protect against the adverse influence of chemicals in the hospital environment: disinfectants, detergents, medicines

  17. Slide 17: Examination Gloves

    EXAMINATION EXAMINATION GLOVES GLOVES h [ LATEX MEDICAL GLOVES FEATURES ���������� GENERAL – MATERIAL/APPLICATION SKIN-FRIENDLY COMFORT OF USE STRENGTH/DURABILITY ELASTICITY SOFTNESS PUNCTURE RESISTANCE TEAR RESISTANCE PROTECTION AGAINST SOLVENTS PROTECTION AGAINST ACIDS AND BASES PROTECTION AGAINST

  18. Slide 18: Surgical Gloves

    SURGICAL SURGICAL GLOVES GLOVES Intended for invasive surgery requiring aseptic conditions. Packed in pairs in hermetic packaging ensuring sterility until the packing is opened. The gloves provide protection against infections in a high-risk environment. They provide the best protection against micr

  19. Slide 19: Household Gloves

    HOUSEHOLD HOUSEHOLD GLOVES GLOVES Intended for gardening, household work and cleaning. Protection minimising the risk. The gloves feature a sweat-absorbing lining facilitating putting the glove on. Different design for the left and the right hand. The gloves have an extended cuff. Fields of use ▪ ho

  20. Slide 20: Medical Gloves

    MEDICAL MEDICAL GLOVES GLOVES BENEFITS OF THE COOPERATION WITH MERCATOR MEDICAL IN THE SCOPE OF MEDICAL GLOVES THE WIDEST OFFER OF GLOVES IN CONTINUOUS SALES IN THE CENTRAL AND EASTERN EUROPE: GLOVE 52 TYPES 6 KINDS OF RAW MATERIALS 5 FOR DIAGNOSTICS 7 FOR SURGERY 18 COLOURS SIZES Biggest stock of g

  21. Slide 21: Non-Woven Products

    NON-WOVEN NON-WOVEN PRODUCTS PRODUCTS surgical field draping, sheets and drapes, medical scrubs. Surgical field draping protects both the By protecting against post-surgery infections, patient and the medical personnel against the drapes reduce the risk infections. They prevent microorganisms of nec

  22. Slide 22: Non-Woven Products

    NON-WOVEN NON-WOVEN PRODUCTS PRODUCTS Single-use drapes are easy to use and significantly shorten the time necessary to prepare a patient for surgery. They feature numerous integrated compound elements such as fluid bags, surgical film, handles. Draping systems opero®set, opero®set tri, opero®drape,

  23. Slide 23: New in the Offer in 2020

    NEW IN THE OFFER IN 2020 WE ARE CONSTANT TO DEVELOP Last year alone, we intro- This is why we make sure We try to respond to the duced 9 types of gloves, that our product portfolio is needs of our clients. and more are being constantly expanding. implemented.

  24. Slide 24: Agenda

    AGENDA COMPANY OVERVIEW OUR PRODUCTS FINANCIAL AND OPERATING RESULTS SUMMARY

  25. Slide 25: Financial and Operating Results

    FINANCIAL AND OPERATING RESULTS

  26. Slide 26: Dynamic Market Growth Accelerated by the COVID-19 Pandemic

    DYNAMIC MARKET GROWTH ACCELERATED BY THE COVID-19 PANDEMIC GLOBAL SALES OF SINGLE-USE GLOVES (BN PCS) 600 514 500 447 400 360 298 300 268 H1N1 233 194 210 +20,8% 200 SARS 171 180 150 148 160 122 124 140 92 94 102 110 100 84 0 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016

  27. Slide 27: Global and Geographically Diversified Activity with Our Own Distribution Network

    GLOBAL AND GEOGRAPHICALLY DIVERSIFIED ACTIVITY WITH OUR OWN DISTRIBUTION NETWORK Change Change 2020 2019 (m PLN) (%) ▪ As a result of such factors as the dynamic increase of market prices of gloves and the persistent surplus of global demand over supply, the United Kingdom 449,0 4,2 444,7 x105 Merca

  28. Slide 28: Impressive Increase of Profitability

    IMPRESSIVE INCREASE OF PROFITABILITY Over 11 times higher EBITDA y/y Over 11 times higher EBITDA y/y EBITDA on a quarterly basis (%) EBITDA on a quarterly basis (%) 62,5% 64,7% 62,2% Production Produkcja 75% 73% 61% Distribution Dystrybucja 52% 54% 48% 17,4% 5,0% 5,8% 5,5% 1,5% Q1 '19 Q2 '19 Q3 '19

  29. Slide 29: Net Profit as a Result of Profitability on Higher Levels of the P&L Account

    NET PROFIT AS A RESULT OF PROFITABILITY ON HIGHER LEVELS OF THE P&L ACCOUNT 935,6 ▪ High conversion into cash in spite of the general market increase of CONSOLIDATED NET restrictiveness of suppliers’ payment policy (cash prepayments): operating PROFIT/LOSS cash flow + 712 m PLN (76% of net profit, 6

  30. Slide 30: Shareholders

    SHAREHOLDERS SHARE IN THE SHARE CAPITAL SHARE IN THE TOTAL NUMBER OF VOTES 36,31% 27,89% 0,15% 0,27% 55,41% 0,39% 67,86% 0,20% 2,84% 0,38% 0,54% 0,83% 2,39% 2,39% Anabaza LTD.* Wiesław Żyznowski Mercator Medical TFI NN Investment Partners SA TFI PZU OFE Metlife TFI Generali Others * Taking into acco

  31. Slide 31: Agenda

    AGENDA COMPANY OVERVIEW OUR PRODUCTS FINANCIAL AND OPERATING RESULTS SUMMARY

  32. Slide 32: Summary

    SSS... MERCATOR SUMMARY

  33. Slide 33: Global Disposable Gloves Market

    GLOBAL DISPOSABLE GLOVES MARKET The value of the global single-use glove market was estimated at 6.71 bn USD in GROWTH FACTORS: 2019 and was expected to grow with CAGR on the level of 11.2% from 2020 to 2027 without the impact of COVID-19. Current market prices are much higher ▪ consistent market gr

  34. Slide 34: SARS-CoV-2 Pandemic

    SARS-CoV-2 Pandemic means a rapid increase in demand for personal protective equipment. The relatively fixed level of supply of single-use gloves naturally led to a dynamic increase of market prices.

  35. Slide 35: New Circumstances, New Opportunities

    NEW CIRCUMSTANCES, NEW OPPORTUNITIES Demand for gloves Single-use gloves Learning considerably increased have become the most more about during a pandemic essential products gloves In accordance with the rules of the new Not only medical personnel, but also When looking for relevant products, sanita

  36. Slide 36: Company's New Strategy – Planning Our Future

    COMPANY’S NEW STRATEGY – PLANNING OUR FUTURE Our Group is working on a new development strategy for the next years. This strategy will take into account not only the current market situation, which should continue in the next quarters, but also the situation of the industry in the post-pandemic peri

  37. Slide 37: Rebranding

    REBRANDING IN 2020, WE COMPLETED THE REBRANDING PROCESS based on changing the brand logo while retaining the existing corporate name

  38. Slide 38: Government Plans – A Support for the Sector in Which We Operate

    GOVERNMENT PLANS – A SUPPORT FOR THE SECTOR IN WHICH WE OPERATE Expected benefits from planned and completed investments with the use of public funds supported by the EU: EU’s Cost reimbursement pharmaceutical procedure for the strategy development of RTR Plus EU4Health Programme – elaborated by the

  39. Slide 39: Caring in Times of a Pandemic

    CARING IN TIMES OF A PANDEMIC #Together Since the beginning of the pandemic, we have been involved in the fight against COVID-19. We are carrying out the #TogetherAgainstTheVirus (#WspólniePrzeciwWirusowi) campaign to support medical against and care facilities by donating personal protective equipm

  40. Slide 40: Recognised and Award-Winning

    RECOGNISED AND AWARD-WINNING The Mercator Medical Group is recognised and appreciated in many contests and competitions due to its dynamic business growth, geographic expansion and strong increase of capitalisation at the Warsaw Stock Exchange. SELECTED PRIZES AND AWARDS: ▪ Rzeczpospolita’s Eagle in

  41. Slide 41: Summary Non-Financial Report

    SUMMARY NON-FINANCIAL REPORT For more information on non- financial activities of the Mercator Medical Group, see the summary non-financial report for the year 2020. The report is available on the website of Mercator Medical in the Investors tab. www.mercatormedical.eu

  42. Slide 42: Contact Us

    contact us Mercator Medical s.a. ul. H. Modrzejewskiej 30 31-327 Kraków ph. +48 12 66 55 400 fax +48 12 66 55 415 e-mail: medical@pl.mercatormedical.eu

Mercator Medical — Investor Presentation (2021) on 6ix